Sonia Rodríguez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sonia Rodríguez has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- David Gonzalez
Facultad de Quimica, Universidad de la Republica, Montevideo, Uruguay
6 shared publications - Paola Panizza
Molecular Microbiology Lab, Bioscience Department, Facultad de Química, Universidad de la República(Udelar), Montevideo, Uruguay
6 shared publications - Paula Rodríguez
Laboratorio de Botánica, Departamento de Química Orgánica, Facultad de Química, Universidad de la República, Montevideo, Uruguay. Laboratorio de Biocatálisis y Biotransformaciones, Departamento de Química Orgánica, Departamento de Biociencias, Facultad de Química, Universidad de la República, Montevideo, Uruguay
6 shared publications Jon D. Stewart
Department of Chemistry, University of Florida, Gainesville, FL 32611, USA
4 shared publications- María Agustina Vila
Laboratorio de Síntesis Orgánica Departamento de Química Orgánica Facultad de Química Universidad de la República (UdelaR) Av. Gral. Flores 2124 Montevideo Uruguay
4 shared publications - Pilar Menéndez
Cátedra de Farmacognosia y Productos Naturales, Facultad de Quimica, General Flores 2124, Montevideo, Uruguay
4 shared publications
Latest Publications
- 26 November 2022
- Published by Springer Nature
- p. 33-42
Detection of Endophytes by Cultivation Method
- Open Access
- 15 June 2022
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 82 (12_Supplem) , 2642
Abstract 2642: BID expression levels determine cell fate upon AURKB inhibition
Background: Aurora kinase B (AURKB) plays a key role in the regulation of mitosis, and AURKB inhibitors are in Phase II-III clinical trials. We reported previously that Chr22q11 amplification, leading to BID overexpression, was associated with apoptosis in upon AURKB inhibition (AURKBi) in NSCLC cell lines resistant to EGFR TKIs. However, it remains to be elucidated whether high levels of BID expression are associated with sensitivity to AURKBi beyond NSCLC and Chr22q11 amplification. Methods: A panel of 11 solid tumor cell lines were used in the study. Also included were the EGFR-mut cell lines PC9 and 11-18, and 36 EGFR-TKI resistant clones derived from them. FISH and Q-PCR were used to determine copy number status; mRNA expression was studied by nCounter and RT-Q-PCR and protein expression by Western blotting. The effects of drugs were analyzed by MTT and flow cytometry. CRISPR-Cas9 technology was used for KO generation while ectopic expression was achieved by cloning the BID gene into a doxycycline-inducible pTRIPZ vector. Finally, in vivo experiments were performed by implanting tumor cells into athymic nude mice. Results: First, we analyzed copy numbers of BID and other 22q11 genes, together with BID expression levels, in the 49 cell lines included in the study. Then, we determined the dose-response curves of the cell lines for AZD2811, a specific AURKB inhibitor. We found that tumor cells with high BID expression levels were consistently sensitive to AURKB inhibition, independently of 22q11 amplification, while cell lines with low BID expression were uniformly resistant (r=0.91, p2=0.97). Western blotting experiments in parental and BID-silenced cells demonstrated that AZD2811 induced apoptosis in sensitive cells by a mechanism mediated by CASP-2 activation, leading to CASP-3 cleavage. In addition, CRISPR KO of the PIDDosome components (CASP-2, PIDD1 and CRADD) mimicked the effects of BID silencing, rendering BID-high expressing cells resistant to AURKB inhibition. Finally, a prevalence study including 118 tumor samples of different solid malignancies revealed high BID mRNA levels in 6% of cases. Conclusions: BID upregulation switches cell fate from survival to apoptosis in response to AURKB inhibition in a wide range of tumor cell lines from different origins. Our results pave the way to clinical exploration of AURKB inhibitors in BID overexpressing tumors. Citation Format: Jordi Bertrán-Alamillo, John Travers, Sara Talbot, Rebecca Whiteley, Ana Giménez-Capitán, Ruth Román, Sonia Rodríguez, Erika Aldeguer, Josep Castellví, Alejandro Martínez-Bueno, Andrea Martella, Jamal Saeh, Giulia Fabbri, Rafael Rosell, Urszula Polanska, Jelena Urosevic, Miguel A. Molina-Vila. BID expression levels determine cell fate upon AURKB inhibition [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 2642.
- 15 June 2022
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 82 (12_Supplem) , 2642
Open AccessAbstract 2642: BID expression levels determine cell fate upon AURKB inhibition
Background: Aurora kinase B (AURKB) plays a key role in the regulation of mitosis, and AURKB inhibitors are in Phase II-III clinical trials. We reported previously that Chr22q11 amplification, leading to BID overexpression, was associated with apoptosis in upon AURKB inhibition (AURKBi) in NSCLC cell lines resistant to EGFR TKIs. However, it remains to be elucidated whether high levels of BID expression are associated with sensitivity to AURKBi beyond NSCLC and Chr22q11 amplification. Methods: A panel of 11 solid tumor cell lines were used in the study. Also included were the EGFR-mut cell lines PC9 and 11-18, and 36 EGFR-TKI resistant clones derived from them. FISH and Q-PCR were used to determine copy number status; mRNA expression was studied by nCounter and RT-Q-PCR and protein expression by Western blotting. The effects of drugs were analyzed by MTT and flow cytometry. CRISPR-Cas9 technology was used for KO generation while ectopic expression was achieved by cloning the BID gene into a doxycycline-inducible pTRIPZ vector. Finally, in vivo experiments were performed by implanting tumor cells into athymic nude mice. Results: First, we analyzed copy numbers of BID and other 22q11 genes, together with BID expression levels, in the 49 cell lines included in the study. Then, we determined the dose-response curves of the cell lines for AZD2811, a specific AURKB inhibitor. We found that tumor cells with high BID expression levels were consistently sensitive to AURKB inhibition, independently of 22q11 amplification, while cell lines with low BID expression were uniformly resistant (r=0.91, p2=0.97). Western blotting experiments in parental and BID-silenced cells demonstrated that AZD2811 induced apoptosis in sensitive cells by a mechanism mediated by CASP-2 activation, leading to CASP-3 cleavage. In addition, CRISPR KO of the PIDDosome components (CASP-2, PIDD1 and CRADD) mimicked the effects of BID silencing, rendering BID-high expressing cells resistant to AURKB inhibition. Finally, a prevalence study including 118 tumor samples of different solid malignancies revealed high BID mRNA levels in 6% of cases. Conclusions: BID upregulation switches cell fate from survival to apoptosis in response to AURKB inhibition in a wide range of tumor cell lines from different origins. Our results pave the way to clinical exploration of AURKB inhibitors in BID overexpressing tumors. Citation Format: Jordi Bertrán-Alamillo, John Travers, Sara Talbot, Rebecca Whiteley, Ana Giménez-Capitán, Ruth Román, Sonia Rodríguez, Erika Aldeguer, Josep Castellví, Alejandro Martínez-Bueno, Andrea Martella, Jamal Saeh, Giulia Fabbri, Rafael Rosell, Urszula Polanska, Jelena Urosevic, Miguel A. Molina-Vila. BID expression levels determine cell fate upon AURKB inhibition [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 2642.
- 13 March 2022
- Published by Taylor & Francis in Biofuels
- Vol. 13 (8) , 965-974
Metabolic engineered E. coli for the production of (R)-1,2-propanediol from biodiesel derived glycerol
The development of the biodiesel industry with the concomitant production of glycerol as the major byproduct has had a negative impact on the glycerol market. The application of circular economy concepts has led to progress in production processes that use this residue as starting material. Propylene glycol has been identified as a potential destiny of glycerol surplus; however, the possibility of increasing this valorization from the existence of a stereogenic center has been scarcely explored. Using metabolic engineering in E. coli, a set of biocatalysts capable of biotransforming glycerol to (R)-1,2-propanediol has been designed, built, and evaluated. The simultaneous expression of a methylglyoxal reductase (Gre2p) and an aldehyde reductase (Ypr1p) both from S. cerevisiae origin, along with the overexpression of E. coli methylglyoxal synthase (mgsA), resulted in an E. coli strain capable of producing enantiomerically pure (e.e.> 99%) (R)-1,2-propanediol from glycerol, in a concentration of 209 ± 9 mg.L-1. The developed biocatalysts presented a satisfactory performance when crude glycerin obtained from biodiesel production process was used in place of glycerol.
- 13 March 2022
- Published by Taylor & Francis in Biofuels
- Vol. 13 (8) , 965-974
Metabolic engineered E. coli for the production of (R)-1,2-propanediol from biodiesel derived glycerol
The development of the biodiesel industry with the concomitant production of glycerol as the major byproduct has had a negative impact on the glycerol market. The application of circular economy concepts has led to progress in production processes that use this residue as starting material. Propylene glycol has been identified as a potential destiny of glycerol surplus; however, the possibility of increasing this valorization from the existence of a stereogenic center has been scarcely explored. Using metabolic engineering in E. coli, a set of biocatalysts capable of biotransforming glycerol to (R)-1,2-propanediol has been designed, built, and evaluated. The simultaneous expression of a methylglyoxal reductase (Gre2p) and an aldehyde reductase (Ypr1p) both from S. cerevisiae origin, along with the overexpression of E. coli methylglyoxal synthase (mgsA), resulted in an E. coli strain capable of producing enantiomerically pure (e.e.> 99%) (R)-1,2-propanediol from glycerol, in a concentration of 209 ± 9 mg.L-1. The developed biocatalysts presented a satisfactory performance when crude glycerin obtained from biodiesel production process was used in place of glycerol.
- Open Access
- 25 November 2021
- Published by Frontiers Media SA in Frontiers in Catalysis
- Vol. 1
Identification, Characterization, and In Silico Analysis of New Imine Reductases From Native Streptomyces Genomes
The development of biocatalytic tools for the synthesis of optically pure amines has been the focus of abundant research in recent years. Among other enzymes, imine reductases have attracted much attention associated with the possibility of attaining chiral secondary amines. Furthermore, the reductive aminase activity associated with some of these enzymes has facilitated the production of optically pure amines from a prochiral ketone, a transformation that opens doors to an incredible array of products. In this work, the genomes from native Streptomyces strains isolated in our lab have been explored on the search for novel imine reductases. Application of different structural criteria and sequence motif filters allowed the identification of two novel enzymes, Ss-IRED_S and Ss-IRED_R. While the former presented outstanding activity towards bulky cyclic imine substrates, the latter presented reductive aminase activity with the assayed ketones. A bioinformatic analysis based on modeling and docking studies was performed in order to explain the differences in enzyme activity, searching for additional criteria that could be used to analyze enzyme candidates in silico, providing additional tools for enzyme selection for a particular application. Our findings suggest that imine reductase activity could be predicted by this analysis, overall accounting for the number of docking positions that meet the catalytic requirements.
- 25 November 2021
- Published by Frontiers Media SA in Frontiers in Catalysis
- Vol. 1
Open AccessIdentification, Characterization, and In Silico Analysis of New Imine Reductases From Native Streptomyces Genomes
The development of biocatalytic tools for the synthesis of optically pure amines has been the focus of abundant research in recent years. Among other enzymes, imine reductases have attracted much attention associated with the possibility of attaining chiral secondary amines. Furthermore, the reductive aminase activity associated with some of these enzymes has facilitated the production of optically pure amines from a prochiral ketone, a transformation that opens doors to an incredible array of products. In this work, the genomes from native Streptomyces strains isolated in our lab have been explored on the search for novel imine reductases. Application of different structural criteria and sequence motif filters allowed the identification of two novel enzymes, Ss-IRED_S and Ss-IRED_R. While the former presented outstanding activity towards bulky cyclic imine substrates, the latter presented reductive aminase activity with the assayed ketones. A bioinformatic analysis based on modeling and docking studies was performed in order to explain the differences in enzyme activity, searching for additional criteria that could be used to analyze enzyme candidates in silico, providing additional tools for enzyme selection for a particular application. Our findings suggest that imine reductase activity could be predicted by this analysis, overall accounting for the number of docking positions that meet the catalytic requirements.
- 1 November 2020
- Published by Elsevier in Molecular Catalysis
- Vol. 495
New mechanistic insights into the reversible aldol reaction catalysed by Rhamnulose-1-phosphate aldolase from Escherichia coli
- 1 November 2020
- Published by Elsevier in Molecular Catalysis
- Vol. 495
New mechanistic insights into the reversible aldol reaction catalysed by Rhamnulose-1-phosphate aldolase from Escherichia coli
- 18 March 2020
- Published by Wiley in ChemBioChem
- Vol. 21 (14) , 1981-1987
C−H Amination via Nitrene Transfer Catalyzed by Mononuclear Non‐Heme Iron‐Dependent Enzymes
Expanding the reaction scope of natural metalloenzymes can provide new opportunities for biocatalysis. Mononuclear non‐heme iron‐dependent enzymes represent a large class of biological catalysts involved in the biosynthesis of natural products and catabolism of xenobiotics, among other processes. Here, we report that several members of this enzyme family, including Rieske dioxygenases as well as α‐ketoglutarate‐dependent dioxygenases and halogenases, are able to catalyze the intramolecular C−H amination of a sulfonyl azide substrate, thereby exhibiting a promiscuous nitrene transfer reactivity. One of these enzymes, naphthalene dioxygenase (NDO), was further engineered resulting in several active site variants that function as C−H aminases. Furthermore, this enzyme could be applied to execute this non‐native transformation on a gram scale in a bioreactor, thus demonstrating its potential for synthetic applications. These studies highlight the functional versatility of non‐heme iron‐dependent enzymes and pave the way to their further investigation and development as promising biocatalysts for non‐native metal‐catalyzed transformations.
- 18 March 2020
- Published by Wiley in ChemBioChem
- Vol. 21 (14) , 1981-1987
C−H Amination via Nitrene Transfer Catalyzed by Mononuclear Non‐Heme Iron‐Dependent Enzymes
Expanding the reaction scope of natural metalloenzymes can provide new opportunities for biocatalysis. Mononuclear non‐heme iron‐dependent enzymes represent a large class of biological catalysts involved in the biosynthesis of natural products and catabolism of xenobiotics, among other processes. Here, we report that several members of this enzyme family, including Rieske dioxygenases as well as α‐ketoglutarate‐dependent dioxygenases and halogenases, are able to catalyze the intramolecular C−H amination of a sulfonyl azide substrate, thereby exhibiting a promiscuous nitrene transfer reactivity. One of these enzymes, naphthalene dioxygenase (NDO), was further engineered resulting in several active site variants that function as C−H aminases. Furthermore, this enzyme could be applied to execute this non‐native transformation on a gram scale in a bioreactor, thus demonstrating its potential for synthetic applications. These studies highlight the functional versatility of non‐heme iron‐dependent enzymes and pave the way to their further investigation and development as promising biocatalysts for non‐native metal‐catalyzed transformations.
- 17 March 2018
- Published by Springer Nature in World Journal of Microbiology and Biotechnology
- Vol. 34 (4) , 50
Endophytic biocatalysts with enoate reductase activity isolated from Mentha pulegium
The biotransformation of (4R)-(−)-carvone by Mentha pulegium (pennyroyal) leaves and its endophytic bacteria was performed in order to search for novel biocatalysts with enoate reductase activity. The obtained results clearly indicated that endophytes play an important role in the biotransformation of (4R)-(−)-carvone with pennyroyal plant tissues. The best activity was associated to the endophytic bacteria Pseudomonas proteolytica FM18Mci1 and Bacillus sp. FM18civ1. Enoate reductase activity for the reduction of (4R)-(−)-carvone and (4S)-(+)-carvone as model substrates was evaluated for each strain. Finally, both isolated strains were evaluated for the kinetic resolution of racemic carvone. The two bacteria gave (1R, 4R) or (1R, 4S)-dihydrocarvone as major products. P. proteolytica FM18Mci1 had preference for the 4S-(−)-carvone, reaching a conversion 95% in 24 h. In contrast, Bacillus sp. FM18civ1 had preference for (4R)-(−)-carvone. The results obtained in the kinetic resolution of carvone indicated that the Bacillus strain could be useful for resolving a racemic mixture of carvone.
- 17 March 2018
- Published by Springer Nature in World Journal of Microbiology and Biotechnology
- Vol. 34 (4) , 50
Endophytic biocatalysts with enoate reductase activity isolated from Mentha pulegium
The biotransformation of (4R)-(−)-carvone by Mentha pulegium (pennyroyal) leaves and its endophytic bacteria was performed in order to search for novel biocatalysts with enoate reductase activity. The obtained results clearly indicated that endophytes play an important role in the biotransformation of (4R)-(−)-carvone with pennyroyal plant tissues. The best activity was associated to the endophytic bacteria Pseudomonas proteolytica FM18Mci1 and Bacillus sp. FM18civ1. Enoate reductase activity for the reduction of (4R)-(−)-carvone and (4S)-(+)-carvone as model substrates was evaluated for each strain. Finally, both isolated strains were evaluated for the kinetic resolution of racemic carvone. The two bacteria gave (1R, 4R) or (1R, 4S)-dihydrocarvone as major products. P. proteolytica FM18Mci1 had preference for the 4S-(−)-carvone, reaching a conversion 95% in 24 h. In contrast, Bacillus sp. FM18civ1 had preference for (4R)-(−)-carvone. The results obtained in the kinetic resolution of carvone indicated that the Bacillus strain could be useful for resolving a racemic mixture of carvone.
- 29 May 2017
- Published by Wiley in Advanced Synthesis & Catalysis
- Vol. 359 (12) , 2149-2157
Site‐Directed Mutagenesis Studies on the Toluene Dioxygenase Enzymatic System: Role of Phenylalanine 366, Threonine 365 and Isoleucine 324 in the Chemo‐, Regio‐, and Stereoselectivity
Toluene Dioxygenase (TDO) enzymatic complex has been widely used as a biocatalyst for the regio‐ and enantioselective preparation of cis‐cyclohexadienediols, which are very important starting materials for organic synthesis. However, the lack of regio‐ and stereodiversity of the dioxygenation process by TDO and related dioxygenases constitutes a clear drawback when planning the use of these diols in synthetic schemes. In this work, we developed three TDO mutants in residues phenylalanine 366, threonine 365 and isoleucine 324, with the aim to alter the chemo‐, regio‐ and stereoselectivity of the biotransformation of arenes. While no changes in the regioselectivity of the process were observed, dramatic variations in the chemo‐ and enantioselectivity were found for mutants I324F, T365N and F366 V in a substrate‐dependent manner. magnified image
- 29 May 2017
- Published by Wiley in Advanced Synthesis & Catalysis
- Vol. 359 (12) , 2149-2157
Site‐Directed Mutagenesis Studies on the Toluene Dioxygenase Enzymatic System: Role of Phenylalanine 366, Threonine 365 and Isoleucine 324 in the Chemo‐, Regio‐, and Stereoselectivity
Toluene Dioxygenase (TDO) enzymatic complex has been widely used as a biocatalyst for the regio‐ and enantioselective preparation of cis‐cyclohexadienediols, which are very important starting materials for organic synthesis. However, the lack of regio‐ and stereodiversity of the dioxygenation process by TDO and related dioxygenases constitutes a clear drawback when planning the use of these diols in synthetic schemes. In this work, we developed three TDO mutants in residues phenylalanine 366, threonine 365 and isoleucine 324, with the aim to alter the chemo‐, regio‐ and stereoselectivity of the biotransformation of arenes. While no changes in the regioselectivity of the process were observed, dramatic variations in the chemo‐ and enantioselectivity were found for mutants I324F, T365N and F366 V in a substrate‐dependent manner. magnified image
- 17 May 2017
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 101 (14) , 5677-5687
Identification, expression and characterization of an R-ω-transaminase from Capronia semiimmersa
Chiral amines are essential precursors in the production of biologically active compounds, including several important drugs. Among the biocatalytic strategies that have been developed for their synthesis, the use of ω-transaminases (ω-TA) appears as an attractive alternative allowing the stereoselective amination of prochiral ketones. However, the problems associated with narrow substrate specificity, unfavourable reaction equilibrium and expensive amine donors still hamper its industrial application. The search for novel enzymes from nature can contribute to expand the catalytic repertoire of ω-TA and help to circumvent some of these problems. A genome mining approach, based on the work described by Höhne et al., was applied for selection of potential R-ω-TA. Additional criteria were used to select an enzyme that differs from previously described ones. A candidate R-ω-TA from Capronia semiimmersa was selected, cloned and expressed in Escherichia coli. Interestingly, alignment of this enzyme with previously reported TA sequences revealed the presence of two additional amino acid residues in a loop close to the active site. The impact of this change was analysed with a structural model based on crystallized R-ω-TAs. Analysis of the substrate specificity of R-ω-TA from C. semiimmersa indicates that it accepts a diversity of ketones as substrates yielding the corresponding amine with good yields and excellent enantioselectivity. The expressed enzyme accepts isopropylamine as amine donor what makes it suitable for industrial processes.
- 17 May 2017
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 101 (14) , 5677-5687
Identification, expression and characterization of an R-ω-transaminase from Capronia semiimmersa
Chiral amines are essential precursors in the production of biologically active compounds, including several important drugs. Among the biocatalytic strategies that have been developed for their synthesis, the use of ω-transaminases (ω-TA) appears as an attractive alternative allowing the stereoselective amination of prochiral ketones. However, the problems associated with narrow substrate specificity, unfavourable reaction equilibrium and expensive amine donors still hamper its industrial application. The search for novel enzymes from nature can contribute to expand the catalytic repertoire of ω-TA and help to circumvent some of these problems. A genome mining approach, based on the work described by Höhne et al., was applied for selection of potential R-ω-TA. Additional criteria were used to select an enzyme that differs from previously described ones. A candidate R-ω-TA from Capronia semiimmersa was selected, cloned and expressed in Escherichia coli. Interestingly, alignment of this enzyme with previously reported TA sequences revealed the presence of two additional amino acid residues in a loop close to the active site. The impact of this change was analysed with a structural model based on crystallized R-ω-TAs. Analysis of the substrate specificity of R-ω-TA from C. semiimmersa indicates that it accepts a diversity of ketones as substrates yielding the corresponding amine with good yields and excellent enantioselectivity. The expressed enzyme accepts isopropylamine as amine donor what makes it suitable for industrial processes.
- 1 March 2017
- Published by Elsevier in Enzyme and Microbial Technology
- Vol. 98, 86-95
A novel thermophilic and halophilic esterase from Janibacter sp. R02, the first member of a new lipase family (Family XVII)
- 1 March 2017
- Published by Elsevier in Enzyme and Microbial Technology
- Vol. 98, 86-95
A novel thermophilic and halophilic esterase from Janibacter sp. R02, the first member of a new lipase family (Family XVII)